These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37435061)

  • 1. AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation.
    Caforio M; Tumino N; Sorino C; Manni I; Di Giovenale S; Piaggio G; Iezzi S; Strimpakos G; Mattei E; Moretta L; Fanciulli M; Vacca P; Locatelli F; Folgiero V
    Front Immunol; 2023; 14():1191908. PubMed ID: 37435061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection?
    Cifaldi L; Doria M; Cotugno N; Zicari S; Cancrini C; Palma P; Rossi P
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Che-1/AATF: A Critical Cofactor for Both Wild-Type- and Mutant-p53 Proteins.
    Bruno T; Iezzi S; Fanciulli M
    Front Oncol; 2016; 6():34. PubMed ID: 26913241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.
    de Andrade LF; Smyth MJ; Martinet L
    Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and structural basis of TIGIT: Nectin-4 interaction, a recently discovered pathway crucial for cancer immunotherapy.
    Ganguli N; Kumari P; Dash S; Samanta D
    Biochem Biophys Res Commun; 2023 Oct; 677():31-37. PubMed ID: 37542773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
    Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
    Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AATF/Che-1-An RNA Binding Protein at the Nexus of DNA Damage Response and Ribosome Biogenesis.
    Kaiser RWJ; Erber J; Höpker K; Fabretti F; Müller RU
    Front Oncol; 2020; 10():919. PubMed ID: 32587828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A
    Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
    Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
    BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
    Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
    Front Immunol; 2021; 12():532484. PubMed ID: 33897679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity.
    Catena V; Bruno T; Iezzi S; Matteoni S; Salis A; Sorino C; Damonte G; Fanciulli M
    J Exp Clin Cancer Res; 2021 Jul; 40(1):232. PubMed ID: 34266450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.
    Fuchs A; Colonna M
    Semin Cancer Biol; 2006 Oct; 16(5):359-66. PubMed ID: 16904340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.
    Wang W; Guo H; Geng J; Zheng X; Wei H; Sun R; Tian Z
    J Biol Chem; 2014 Nov; 289(48):33311-9. PubMed ID: 25315772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity.
    Voskens CJ; Watanabe R; Rollins S; Campana D; Hasumi K; Mann DL
    J Exp Clin Cancer Res; 2010 Oct; 29(1):134. PubMed ID: 20937115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
    Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
    Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
    Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
    [No Abstract]   [Full Text] [Related]  

  • 20. AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.
    Höpker K; Hagmann H; Khurshid S; Chen S; Hasskamp P; Seeger-Nukpezah T; Schilberg K; Heukamp L; Lamkemeyer T; Sos ML; Thomas RK; Lowery D; Roels F; Fischer M; Liebau MC; Resch U; Kisner T; Röther F; Bartram MP; Müller RU; Fabretti F; Kurschat P; Schumacher B; Gaestel M; Medema RH; Yaffe MB; Schermer B; Reinhardt HC; Benzing T
    EMBO J; 2012 Oct; 31(20):3961-75. PubMed ID: 22909821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.